Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...

Reagenics Research produces protein inside potatoes via plant cell culture, and studies show its low methionine content can help build muscle and slow ageing. Could the spud be the key to longevity?

Celcuity recently reported in the Journal of Clinical Oncology that its Phase 3 VIKTORIA-1 trial in PIK3CA wild-type HR-positive, HER2-negative advanced breast cancer showed gedatolisib-based regimens ...

A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...

As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) ...

Scientists find finerenone may stimulate ovarian follicles and help restore fertility in women with POI, offering a potential ...

Premature ovarian insufficiency (POI) affects 1–3% of women and has limited treatment options. Researchers report that ovarian fibrosis may restrict follicle development and that the antifibrotic drug ...

A wave of recent neuroscience research has identified specific molecular and cellular mechanisms through which alcohol disrupts signaling between brain cells, offering a sharper picture of how ...

Acquisition of Faeth and concurrent $200 million private investment positions the combined company to advance its pipeline across key clinical milestones in endometrial and breast cancer PIKTOR is an ...

The structural and functional characteristics of mitochondria shape their role as signaling organelles, with far-reaching effects regarding immune responses, inflammatory processes, and diseases. A ...

Gedatolisib targets HR+/HER2-, PIK3CA wild-type advanced breast cancer, with a PDUFA goal date of July 17, 2026. The drug's multi-target approach inhibits all four class 1 PI3K isoforms, mTORC1, and ...

New research highlights amivantamab's potential in enhancing treatment outcomes for RAS/BRAF wild-type metastatic colorectal cancer, addressing resistance to standard therapies. In the evolving ...